Sumitomo Dainippon Pharma Co Ltd (4506)

Currency in JPY
2,173.5
-18.5(-0.84%)
Delayed Data·

Sumitomo Dainippon Pharma Co Ltd Company Profile

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Employees
3832
Market
Japan

Contact Information

Address
6-8, Doshomachi 2-chome Chuo-ku, Osaka, 541-0045, Japan
Phone
81 6 6203 5321
Fax
81 6 6202 6028

Top Executives

Name
Title
Since
Age
Toru KimuraPresident, CEO & Representative Director202466
Tsutomu NakagawaManaging Executive Officer & Director202458
Motoyuki SakaiEVP of Glob. Corp. Strat., Glob. Fin. Admin. Ext. Aff., Corp. Gov., IT Mngt., Data Anly. & Rep. Dir202565
Yoshio IteyaOutside Independent Director202570
Hisayoshi KashimaDirector202565
Minoru UsuiIndependent Outside Director202171
Mayumi MochizukiOutside Independent Director202572
Koji FujimotoIndependent Outside Director202263
Daishiro MichimoriOutside Independent Director202570
Hiroshi NiinumaDirector202468
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.